About the Company
We do not have any company description for BIOMARIN PHARMACEUTICAL INC at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BMRN News
Elliott Waives BioMarin Board Deal, Quashing Lawsuit
In a dramatic shift in corporate strategy, Elliott Investment Management LP has relinquished an earlier pact with BioMarin ...
Biomarin Pharmaceutical Inc BMRN
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
BioMarin Pharmaceutical (BMRN) Expected to Beat Earnings Estimates: Should You Buy?
BioMarin Pharmaceutical (BMRN) is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended March 2024. This widely-known ...
Buy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Sales Outlook and Optimized Market Expectations
Wells Fargo analyst Mohit Bansal has maintained their bullish stance on BMRN stock, giving a Buy rating on April 12. Mohit Bansal has given ...
Jim Cramer's Five Best Stock Picks for the Biotech Sector
TheStreet Ratings team rates BIOMARIN PHARMACEUTICAL INC as a Hold with a ratings score of C-. TheStreet Ratings Team has this to say about their recommendation: "We rate BIOMARIN PHARMACEUTICAL ...
Insider Sell: Biomarin Pharmaceutical Inc (BMRN) Chief Accounting Officer Erin Burkhart ...
Biomarin Pharmaceutical Inc (NASDAQ:BMRN), a global biotechnology company focused on developing and commercializing ...
BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products ...
BioMarin Pharmaceutical Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
BioMarin Pharmaceutical Inc. (BMRN)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Loading the latest forecasts...